Editorial: Identification of therapeutic targets and novel biomarkers in prostate cancer volume II

por Sharad, Shashwat, Srinivasan, Alagarsamy
Publicado 2023

PMEPA1 Gene Isoforms: A Potential Biomarker and Therapeutic Target in Prostate Cancer

por Sharad, Shashwat, Dobi, Albert, Srivastava, Shiv, Srinivasan, Alagarsamy, Li, Hua
Publicado 2020

Neuronal apoptosis by HIV-1 Vpr: contribution of proinflammatory molecular networks from infected target cells

por Guha, Debjani, Nagilla, Pruthvi, Redinger, Carrie, Srinivasan, Alagarsamy, Schatten, Gerald P, Ayyavoo, Velpandi
Publicado 2012

Preexisting vs. de novo antibodies against SARS-CoV-2 in individuals without or with virus infection: impact on antibody therapy, vaccine research and serological testing

por Muthumani, Kar, Xu, Ziyang, Jeong, Moonsup, Maslow, Joel N., Kalyanaraman, Vaniambadi S., Srinivasan, Alagarsamy
Publicado 2021

Combined effects of hyperglycemic conditions and HIV-1 Nef: a potential model for induced HIV neuropathogenesis

por Acheampong, Edward A, Roschel, Cassandra, Mukhtar, Muhammad, Srinivasan, Alagarsamy, Rafi, Mohammad, Pomerantz, Roger J, Parveen, Zahida
Publicado 2009

Landscape of humoral immune responses against SARS-CoV-2 in patients with COVID-19 disease and the value of antibody testing

por Mahalingam, Sundarasamy, Peter, John, Xu, Ziyang, Bordoloi, Devivasha, Ho, Michelle, Kalyanaraman, Vaniambadi S., Srinivasan, Alagarsamy, Muthumani, Kar
Publicado 2021

Genomic alterations of Tenascin C in highly aggressive prostate cancer: a meta-analysis

por Mishra, Prachi, Kiebish, Michael A., Cullen, Jennifer, Srinivasan, Alagarsamy, Patterson, Aliyah, Sarangarajan, Rangaprasad, Narain, Niven R., Dobi, Albert
Publicado 2019

Characterization of unique PMEPA1 gene splice variants (isoforms d and e) from RNA Seq profiling provides novel insights into prognostic evaluation of prostate cancer

por Sharad, Shashwat, Dillman, Allissa Amanda, Sztupinszki, Zsófia M., Szallasi, Zoltan, Rosner, Inger, Cullen, Jennifer, Srivastava, Shiv, Srinivasan, Alagarsamy, Li, Hua
Publicado 2020

Immunotherapy of prostate cancer using novel synthetic DNA vaccines targeting multiple tumor antigens

por Bordoloi, Devivasha, Xiao, Peng, Choi, Hyeree, Ho, Michelle, Perales-Puchalt, Alfredo, Khoshnejad, Makan, Kim, J. Joseph, Humeau, Laurent, Srinivasan, Alagarsamy, Weiner, David B., Muthumani, Kar
Publicado 2021

A comprehensive analysis of the naturally occurring polymorphisms in HIV-1 Vpr: Potential impact on CTL epitopes

por Srinivasan, Alagarsamy, Ayyavoo, Velpandi, Mahalingam, Sundarasamy, Kannan, Aarthi, Boyd, Anne, Datta, Debduti, Kalyanaraman, Vaniambadi S, Cristillo, Anthony, Collman, Ronald G, Morellet, Nelly, Sawaya, Bassel E, Murali, Ramachandran
Publicado 2008

Human immunodeficiency virus type 1 Vpr: oligomerization is an essential feature for its incorporation into virus particles

por Venkatachari, Narasimhan J, Walker, Leah A, Tastan, Oznur, Le, Thien, Dempsey, Timothy M, Li, Yaming, Yanamala, Naveena, Srinivasan, Alagarsamy, Klein-Seetharaman, Judith, Montelaro, Ronald C, Ayyavoo, Velpandi
Publicado 2010

Analysis of PMEPA1 Isoforms (a and b) as Selective Inhibitors of Androgen and TGF-β Signaling Reveals Distinct Biological and Prognostic Features in Prostate Cancer

por Sharad, Shashwat, Sztupinszki, Zsófia M., Chen, Yongmei, Kuo, Claire, Ravindranath, Lakshmi, Szallasi, Zoltan, Petrovics, Gyorgy, Sreenath, Taduru L., Dobi, Albert, Rosner, Inger L., Srinivasan, Alagarsamy, Srivastava, Shiv, Cullen, Jennifer, Li, Hua
Publicado 2019

Methylation of the PMEPA1 gene, a negative regulator of the androgen receptor in prostate cancer

por Sharad, Shashwat, Ravindranath, Lakshmi, Haffner, Michael C, Li, Hua, Yan, Wusheng, Sesterhenn, Isabell A, Chen, Yongmei, Ali, Amina, Srinivasan, Alagarsamy, McLeod, David G, Yegnasubramanian, Srinivasan, Srivastava, Shiv, Dobi, Albert, Petrovics, Gyorgy
Publicado 2014

Functional antagonism of TMPRSS2-ERG splice variants in prostate cancer

por Rastogi, Anshu, Tan, Shyh-Han, Mohamed, Ahmed A., Chen, Yongmei, Hu, Ying, Petrovics, Gyorgy, Sreenath, Taduru, Kagan, Jacob, Srivastava, Sudhir, McLeod, David G., Sesterhenn, Isabell A., Srivastava, Shiv, Dobi, Albert, Srinivasan, Alagarsamy
Publicado 2014

Autoantibodies against oncogenic ERG protein in prostate cancer: potential use in diagnosis and prognosis in a panel with C-MYC, AMACR and HERV-K Gag

por Rastogi, Anshu, Ali, Amina, Tan, Shyh-Han, Banerjee, Sreedatta, Chen, Yongmei, Cullen, Jennifer, Xavier, Charles P., Mohamed, Ahmed A., Ravindranath, Lakshmi, Srivastav, Jigisha, Young, Denise, Sesterhenn, Isabell A., Kagan, Jacob, Srivastava, Sudhir, McLeod, David G., Rosner, Inger L., Petrovics, Gyorgy, Dobi, Albert, Srivastava, Shiv, Srinivasan, Alagarsamy
Publicado 2016

Molecular profiling of radical prostatectomy tissue from patients with no sign of progression identifies ERG as the strongest independent predictor of recurrence

por Yan, Wusheng, Jamal, Muhammad, Tan, Shyh-Han, Song, Yingjie, Young, Denise, Chen, Yongmei, Katta, Shilpa, Ying, Kai, Ravindranath, Lakshmi, Woodle, Tarah, Kohaar, Indu, Cullen, Jennifer, Kagan, Jacob, Srivastava, Sudhir, Dobi, Albert, McLeod, David G., Rosner, Inger L., Sesterhenn, Isabell A., Srinivasan, Alagarsamy, Srivastava, Shiv, Petrovics, Gyorgy
Publicado 2019

Multi-omic serum biomarkers for prognosis of disease progression in prostate cancer

por Kiebish, Michael A., Cullen, Jennifer, Mishra, Prachi, Ali, Amina, Milliman, Eric, Rodrigues, Leonardo O., Chen, Emily Y., Tolstikov, Vladimir, Zhang, Lixia, Panagopoulos, Kiki, Shah, Punit, Chen, Yongmei, Petrovics, Gyorgy, Rosner, Inger L., Sesterhenn, Isabell A., McLeod, David G., Granger, Elder, Sarangarajan, Rangaprasad, Akmaev, Viatcheslav, Srinivasan, Alagarsamy, Srivastava, Shiv, Narain, Niven R., Dobi, Albert
Publicado 2020

Identification of Novel Neutralizing Monoclonal Antibodies against SARS-CoV-2 Spike Glycoprotein

por Bordoloi, Devivasha, Xu, Ziyang, Ho, Michelle, Purwar, Mansi, Bhojnagarwala, Pratik, Cassel, Joel, Giron, Leila B., Walker, Susanne, Kulkarni, Abhijeet J, Ruiz, Edgar Tello, Choi, Jihae, Zaidi, Faraz I., Wu, Yuanhan, Wang, Shaoying, Patel, Ami, Ramos, Stephanie, Smith, Trevor, Kulp, Daniel, Ugen, Kenneth E., Srinivasan, Alagarsamy, Abdel-Mohsen, Mohamed, Humeau, Laurent, Weiner, David B., Muthumani, Kar
Publicado 2021

Analytical platform evaluation for quantification of ERG in prostate cancer using protein and mRNA detection methods

por He, Jintang, Schepmoes, Athena A, Shi, Tujin, Wu, Chaochao, Fillmore, Thomas L, Gao, Yuqian, Smith, Richard D, Qian, Wei-Jun, Rodland, Karin D, Liu, Tao, Camp, David G, Rastogi, Anshu, Tan, Shyh-Han, Yan, Wusheng, Mohamed, Ahmed A, Huang, Wei, Banerjee, Sreedatta, Kagan, Jacob, Srivastava, Sudhir, McLeod, David G, Srivastava, Shiv, Petrovics, Gyorgy, Dobi, Albert, Srinivasan, Alagarsamy
Publicado 2015

Clinical utility of a serum biomarker panel in distinguishing prostate cancer from benign prostate hyperplasia

por Kiebish, Michael A., Tekumalla, Poornima, Ravipaty, Shobha, Dobi, Albert, Srivastava, Shiv, Wu, Wenfang, Patil, Saurabh, Friss, Tracey, Klotz, Allison, Srinivasan, Alagarsamy, Cullen, Jennifer, Rosner, Inger L., Ali, Amina, Laszlo, Sandra, Petrovic, Michele, Fleshner, Neil, Garren, Jeonifer, Miller, Greg, Mahaveer Chand, Nischal, Rodrigues, Leonardo O., Granger, Elder, Kellogg, Mark D., Luan, Shen, Diamandis, Eleftherios, Akmaev, Viatcheslav R., Sarangarajan, Rangaprasad, Bountra, Chas, Freedland, Stephen J., McLeod, David G., Narain, Niven R.
Publicado 2021